Bioequiv.Bioequiv.
HealthyBioequiv.Recruiting폐경여성

[폐경 μ—¬μ„±λŒ€μƒ] λ§ν¬λ“œλ°”μ΄μ˜€ - ν”„λ‘œκ²ŒμŠ€ν…Œλ‘  μ§€μ›μž λͺ¨μ§‘

Trial start date
2026.10.29D-5
Trial siteμ„ΌνŠΈλŸ΄λ³‘μ›κ²½κΈ° μ‹œν₯μ‹œ 곡단1λŒ€λ‘œ 237 9μΈ΅ μž„μƒμ‹œν—˜μ„Όν„°
Screening period2026.09.29 ~ 2026.10.30(Choose date/time when applying)
Trial end date2026.11.16
Trial schedule

<1κΈ° 일정>

  • 10μ›” 30일(금) – μ˜€ν›„ 5μ‹œκ²½ μž„μƒμ‹œν—˜μ„Όν„°μ— μž…μ›

  • 10μ›” 31일(ν† ) – μž…μ› 쀑 μ§„ν–‰

  • 11μ›” 01일(일) – μ˜€μ „ 8μ‹œκ²½ 일정 μ§„ν–‰ ν›„ κ·€κ°€ (μ•½ ν•œμ‹œκ°„ λ‚΄μ™Έ μ†Œμš”)

  • 11μ›” 01일(일) – μ˜€ν›„ 7μ‹œ 30λΆ„κ²½ μž„μƒμ„Όν„° λ°©λ¬Έ ν›„ 일정 μ§„ν–‰ ν›„ κ·€κ°€ (μ•½ ν•œμ‹œκ°„ λ‚΄μ™Έ μ†Œμš”)

  • 11μ›” 02일(μ›”) – μ˜€μ „ 7μ‹œ 30λΆ„κ²½ μž„μƒμ„Όν„° λ°©λ¬Έ ν›„ 일정 μ§„ν–‰ ν›„ κ·€κ°€ (μ˜€μ „8μ‹œλΆ€ν„° μ•½ ν•œμ‹œκ°„ λ‚΄μ™Έ μ†Œμš”)

<2κΈ° 일정>

  • 11μ›” 06일(금) – μ˜€ν›„ 5μ‹œκ²½ μž„μƒμ‹œν—˜μ„Όν„°μ— μž…μ›

  • 11μ›” 07일(ν† ) – μž…μ› 쀑 μ§„ν–‰

  • 11μ›” 08일(일) – μ˜€μ „ 8μ‹œκ²½ 일정 μ§„ν–‰ ν›„ κ·€κ°€ (μ•½ ν•œμ‹œκ°„ λ‚΄μ™Έ μ†Œμš”)

  • 11μ›” 08일(일) – μ˜€ν›„ 7μ‹œ 30λΆ„κ²½ μž„μƒμ„Όν„° λ°©λ¬Έ 일정 μ§„ν–‰ ν›„ κ·€κ°€ (μ•½ ν•œμ‹œκ°„ λ‚΄μ™Έ μ†Œμš”)

  • 11μ›” 09일(μ›”) – μ˜€μ „ 7μ‹œ 30λΆ„κ²½ μž„μƒμ„Όν„° λ°©λ¬Έ ν›„ 일정 μ§„ν–‰ ν›„ κ·€κ°€ (μ˜€μ „8μ‹œλΆ€ν„° μ•½ ν•œμ‹œκ°„ λ‚΄μ™Έ μ†Œμš”)

<μ’…λ£Œλ°©λ¬Έ 일정>

  • 11μ›” 17일(ν™”) – μ˜€μ „ 7μ‹œ 30λΆ„κ²½ μž„μƒμ„Όν„° λ°©λ¬Έ ν›„ 일정진행 ν›„ κ·€κ°€ (μ˜€μ „8μ‹œλΆ€ν„° μ•½ ν•œμ‹œκ°„ λ‚΄μ™Έ μ†Œμš”)

MediCLEO (CLEO) safely and transparently connects participants with clinical and bioequivalence trials. See ongoing trials at a glance and apply with ease.

슀페둜 μ£Όμ‹νšŒμ‚¬ Β· CEO μ‘°λ―Έν˜„ Β· μ„œμšΈνŠΉλ³„μ‹œ 마포ꡬ μ–‘ν™”λ‘œ 19, 4μΈ΅(합정동, ν•©μ •μ˜€ν”ΌμŠ€λΉŒλ”©)

Business Registration No. 367-86-01018 Β· Tel 010-2604-0216

Β© 2026 λ©”λ””ν΄λ ˆμ˜€. Participation in a clinical trial should be decided voluntarily after a full explanation.